Skip to Main Content

Paper Details

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions.
JNCI Cancer Spectr
13
2019
BC, Estrogen, Estrogen Receptor, Estrogen Receptor-Positive Breast Cancer, cancer, estrogen, estrogen receptor, estrogen receptor-, patient, patients
Author NameAffiliation
David W CesconPrincess Margaret Cancer Centre, University Health Network
David W CesconUniversity of Toronto
Funda Meric-BernstamUniversity of Texas MD Anderson Cancer Center
Lisa A CareyLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Larissa A KordeNational Cancer Institute
Meredith M ReganDana-Farber Cancer Institute, Harvard Medical School
Daniel SchramekLunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital
Daniel SchramekUniversity of Toronto
Antonio C WolffThe Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center
James R WoodgettLunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital
  • 1 - 10

Datasets

Release 1.2